細胞培養設備市場規模、佔有率和成長分析：按產品類型、應用、用途、企業規模、最終用戶和地區分類－2026-2033年產業預測

2024 年全球細胞培養設備市場價值為 238 億美元，預計到 2033 年將成長至 675 億美元，而 2025 年為 267.2 億美元，預測期（2026-2033 年）的複合年成長率為 12.28%。

全球細胞培養設備市場的主要驅動力是先進生物製藥和個人化療法日益成長的需求，這導致全球實驗室基礎設施發生顯著變化。這些儀器包括生物反應器、培養箱、自動細胞計數器和輔助設備，對研究、診斷和生產至關重要。其成長反映了向高通量、符合GMP規範的工作流程的轉變，這對於疫苗開發、單株抗體生產和再生醫學至關重要。對可擴展的一次性系統和自動化技術的投入增加，預示著細胞培養正從實驗室規模向商業化生產過渡。自動化、一次性技術和封閉式系統技術的整合滿足了有關可追溯性和合規性的監管要求，降低了人為錯誤和污染的風險，同時為供應商提供了提供整合解決方案的機會，從而提高效率並支持大規模細胞治療和疫苗生產。

全球細胞培養設備市場的成長要素

全球細胞培養設備市場的主要驅動力是生物製藥需求的成長和細胞療法的進步。隨著再生醫學和個人化醫療研究的深入，高效、高品質的細胞培養系統變得至關重要。此外，生物技術產業的蓬勃發展以及研發投入的增加也推動了細胞培養技術的創新。除了致力於開發新型治療藥物外，慢性疾病的日益普遍也增加了對高效細胞培養過程的需求，促使各機構努力提高生產效率並最佳化工作流程，從而推動市場成長。

全球細胞培養設備市場的限制因素

全球細胞培養設備市場的主要限制因素之一是高效細胞培養製程所需的先進技術和設備的高成本。對於預算和資源有限的中小型企業和學術研究機構而言，這種經濟負擔尤其具有挑戰性。此外，複雜的細胞培養技術法律制度也可能導致延誤和合規成本增加。這些因素綜合起來，會限制企業取得尖端設備，並構成進入競爭激烈的細胞培養技術市場的壁壘，進而可能阻礙市場成長。

全球細胞培養設備市場趨勢

全球細胞培養設備市場正呈現顯著的自動化趨勢，這主要得益於實驗室對標準化和可重複工作流程的需求。隨著實驗室努力減少人為因素並提高通量，自動化細胞培養系統的應用日益普及。整合機器人、即時感測器和軟體編配方面的創新，透過實現封閉回路型製程控制和遠端監控，提高了不同規模培養的一致性。供應商正優先考慮互通性、模組化和使用者友善介面，以簡化部署和培訓流程。這種轉變不僅將員工的角色轉變為監督和數據管理，而且還加速了研究流程向細胞治療和生技藥品生產等商業性應用領域的快速轉換。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球細胞培養設備市場規模：依產品類型分類

• 生物反應器和發酵罐
• 細胞培養容器
• 培養箱
• 生物安全櫃
• 離心機
• 顯微鏡和成像系統
• 過濾和滅菌設備
• 細胞計數和分析設備
• 冷凍保存裝置
• 自動化細胞培養系統
• 其他

全球細胞培養設備市場規模：依應用領域分類

• 生物製藥生產
• 疫苗生產
• 再生醫學和幹細胞研究
• 癌症研究
• 藥物發現與開發
• 毒性測試
• 組織工程
• 診斷
• 出於學術和研究目的
• 其他

全球細胞培養設備市場規模：依用途類型分類

• 免洗設備
• 不銹鋼/可重複使用設備

全球細胞培養設備市場規模：依企業規模分類

• 實驗室規模
• 中試規模
• 商業和生產規模

全球細胞培養設備市場規模：依最終用戶分類

• 生物製藥和生物技術公司
• 學術研究機構
• 受託研究機構（CRO）
• 合約研發生產組織（CDMO/CMO）
• 醫院/診斷檢查室
• 細胞庫和組織庫
• 其他

全球細胞培養設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• Danaher Corporation
• Sartorius AG
• Merck KGaA
• Eppendorf SE
• Corning Incorporated
• Avantor
• Agilent Technologies
• Becton, Dickinson and Company
• Getinge AB
• PHC Holdings Corporation
• Hitachi Ltd.
• FUJIFILM Holdings Corporation
• Lonza Group AG
• Esco Lifesciences Group
• Hamilton Company
• Bio-Rad Laboratories
• CellGenix GmbH
• Nuaire
• INFORS HT

結論與建議

Global Cell Culture Equipment Market size was valued at USD 23.8 Billion in 2024 and is poised to grow from USD 26.72 Billion in 2025 to USD 67.5 Billion by 2033, growing at a CAGR of 12.28% during the forecast period (2026-2033).

The global cell culture equipment market is primarily driven by the rising need for advanced biologics and personalized therapies, resulting in significant changes to laboratory infrastructure worldwide. Comprising bioreactors, incubators, automated cell counters, and ancillary devices, this equipment is essential for research, diagnostics, and manufacturing. Its growth reflects a trend toward high-throughput, GMP-compliant workflows essential for vaccine development, monoclonal antibody production, and regenerative medicine. Increasing investments in scalable single-use systems and automation signal a transition from bench-scale to commercial production. The integration of automation with single-use and closed-system technologies addresses regulatory demands for traceability and compliance, reducing human error and contamination risks while presenting opportunities for vendors to offer integrated solutions that enhance efficiency and support cell therapy and vaccine production at scale.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Culture Equipment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Culture Equipment Market Segments Analysis

Global cell culture equipment market is segmented by product type, application, usage type, scale of operation, end user and region. Based on product type, the market is segmented into Bioreactors & Fermenters, Cell Culture Vessels, Incubators, Biosafety Cabinets, Centrifuges, Microscopes & Imaging Systems, Filtration & Sterilization Equipment, Cell Counters & Analyzers, Cryopreservation Equipment, Automated Cell Culture Systems and Others. Based on application, the market is segmented into Biopharmaceutical Production, Vaccine Production, Regenerative Medicine & Stem Cell Research, Cancer Research, Drug Discovery & Development, Toxicity Testing, Tissue Engineering, Diagnostics, Academic & Research Applications and Others. Based on usage type, the market is segmented into Single-Use Equipment and Stainless Steel/Re-Usable Equipment. Based on scale of operation, the market is segmented into Laboratory Scale, Pilot Scale and Commercial/Production Scale. Based on end user, the market is segmented into Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Contract Development & Manufacturing Organizations (CDMOs/CMOs), Hospitals & Diagnostic Laboratories, Cell Banks & Tissue Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Culture Equipment Market

The global cell culture equipment market is primarily driven by the increasing demand for biopharmaceuticals and advancements in cell-based therapies. As research in regenerative medicine and personalized medicine expands, the need for efficient, high-quality cell culture systems becomes imperative. Additionally, the growth of the biotechnology sector and rising investments in research and development foster innovation in cell culture technologies. The focus on developing novel therapeutic products, along with the growing prevalence of chronic diseases, enhances the need for effective cell culture processes, driving market growth as organizations strive for improved production outputs and streamlined workflows.

Restraints in the Global Cell Culture Equipment Market

One significant market restraint for the global cell culture equipment market is the high costs associated with advanced technologies and equipment needed for effective cell culture processes. This financial burden can be particularly challenging for small and medium-sized enterprises (SMEs) and academic research institutions, which may have limited budgets and resources. Furthermore, the complex regulatory environment governing the use of cell culture technologies can lead to delays and increased compliance costs. These factors combined can impede market growth by restricting access to state-of-the-art equipment and creating barriers for new entrants in the competitive landscape of cell culture technologies.

Market Trends of the Global Cell Culture Equipment Market

The Global Cell Culture Equipment market is witnessing a significant trend towards automation, driven by laboratories' demand for standardized and reproducible workflows. As entities seek to minimize manual variability and enhance throughput, the adoption of automated cell culture systems is becoming increasingly prevalent. Innovations in integrated robotics, real-time sensors, and software orchestration facilitate closed-loop process control and allow for remote monitoring, thereby improving consistency across various scales. Vendors are prioritizing interoperability, modularity, and user-friendly interfaces, streamlining implementation and training. This shift not only transforms workforce roles towards oversight and data management but also accelerates the translation of research processes into commercial applications in cell therapy and biologics manufacturing.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cell Culture Equipment Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Bioreactors & Fermenters
• Cell Culture Vessels
• Incubators
• Biosafety Cabinets
• Centrifuges
• Microscopes & Imaging Systems
• Filtration & Sterilization Equipment
• Cell Counters & Analyzers
• Cryopreservation Equipment
• Automated Cell Culture Systems
• Others

Global Cell Culture Equipment Market Size by Application & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical Production
• Vaccine Production
• Regenerative Medicine & Stem Cell Research
• Cancer Research
• Drug Discovery & Development
• Toxicity Testing
• Tissue Engineering
• Diagnostics
• Academic & Research Applications
• Others

Global Cell Culture Equipment Market Size by Usage Type & CAGR (2026-2033)

• Market Overview
• Single-Use Equipment
• Stainless Steel/Re-Usable Equipment

Global Cell Culture Equipment Market Size by Scale of Operation & CAGR (2026-2033)

• Market Overview
• Laboratory Scale
• Pilot Scale
• Commercial/Production Scale

Global Cell Culture Equipment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Biopharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Contract Development & Manufacturing Organizations (CDMOs/CMOs)
• Hospitals & Diagnostic Laboratories
• Cell Banks & Tissue Banks
• Others

Global Cell Culture Equipment Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Usage Type, Scale of Operation, End User)
  • US
  • Canada
• Europe (Product Type, Application, Usage Type, Scale of Operation, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Usage Type, Scale of Operation, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Usage Type, Scale of Operation, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Usage Type, Scale of Operation, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Lifesciences Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CellGenix GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuaire
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INFORS HT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations